87 related articles for article (PubMed ID: 30664534)
21. The expression of miRNA-221 and miRNA-222 in gliomas patients and their prognosis.
Xue L; Wang Y; Yue S; Zhang J
Neurol Sci; 2017 Jan; 38(1):67-73. PubMed ID: 27629767
[TBL] [Abstract][Full Text] [Related]
22. Prostaglandin F2 receptor inhibitor overexpression predicts advanced who grades and adverse prognosis in human glioma tissue.
Chen HW; Lin MC; Wu PR; Chang YC; Weng SS; Tsai WC
Chin J Physiol; 2022; 65(2):93-102. PubMed ID: 35488675
[TBL] [Abstract][Full Text] [Related]
23. Clinical significance of FOXP3 expression in human gliomas.
Wang L; Zhang B; Xu X; Zhang S; Yan X; Kong F; Feng X; Wang J
Clin Transl Oncol; 2014 Jan; 16(1):36-43. PubMed ID: 23579918
[TBL] [Abstract][Full Text] [Related]
24. Epigenetic silencing of XAF1 in high-grade gliomas is associated with IDH1 status and improved clinical outcome.
Reich TR; Switzeny OJ; Renovanz M; Sommer C; Kaina B; Christmann M; Tomicic MT
Oncotarget; 2017 Feb; 8(9):15071-15084. PubMed ID: 28122345
[TBL] [Abstract][Full Text] [Related]
25. Endothelin B receptor expression in malignant gliomas: the perivascular immune escape mechanism of gliomas.
Nakashima S; Sugita Y; Miyoshi H; Arakawa F; Muta H; Ishibashi Y; Niino D; Ohshima K; Terasaki M; Nakamura Y; Morioka M
J Neurooncol; 2016 Mar; 127(1):23-32. PubMed ID: 26645886
[TBL] [Abstract][Full Text] [Related]
26. miR-146b-5p functions as a tumor suppressor by targeting TRAF6 and predicts the prognosis of human gliomas.
Liu J; Xu J; Li H; Sun C; Yu L; Li Y; Shi C; Zhou X; Bian X; Ping Y; Wen Y; Zhao S; Xu H; Ren L; An T; Wang Q; Yu S
Oncotarget; 2015 Oct; 6(30):29129-42. PubMed ID: 26320176
[TBL] [Abstract][Full Text] [Related]
27. PART1 and hsa-miR-429-Mediated SHCBP1 Expression Is an Independent Predictor of Poor Prognosis in Glioma Patients.
Xuan C; Jin M; Wang L; Xue S; An Q; Sun Q; Wang L; Gao Y
Biomed Res Int; 2020; 2020():1767056. PubMed ID: 32351983
[TBL] [Abstract][Full Text] [Related]
28. Downregulation of chromatin remodeling factor CHD5 is associated with a poor prognosis in human glioma.
Wang L; He S; Tu Y; Ji P; Zong J; Zhang J; Feng F; Zhao J; Gao G; Zhang Y
J Clin Neurosci; 2013 Jul; 20(7):958-63. PubMed ID: 23707602
[TBL] [Abstract][Full Text] [Related]
29. Expression of far upstream element (FUSE) binding protein 1 in human glioma is correlated with c-Myc and cell proliferation.
Ding Z; Liu X; Liu Y; Zhang J; Huang X; Yang X; Yao L; Cui G; Wang D
Mol Carcinog; 2015 May; 54(5):405-15. PubMed ID: 24347226
[TBL] [Abstract][Full Text] [Related]
30. IDH1 status is significantly different between high-grade thalamic and superficial gliomas.
Zuo M; Li M; Chen N; Yu T; Kong B; Liang R; Wang X; Mao Q; Liu Y
Cancer Biomark; 2017 Aug; 20(2):183-189. PubMed ID: 28869450
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-210 overexpression predicts poorer prognosis in glioma patients.
Lai NS; Dong QS; Ding H; Miao ZL; Lin YC
J Clin Neurosci; 2014 May; 21(5):755-60. PubMed ID: 24382515
[TBL] [Abstract][Full Text] [Related]
32. Nidogen-1 expression is associated with overall survival and temozolomide sensitivity in low-grade glioma patients.
Zhang B; Xu C; Liu J; Yang J; Gao Q; Ye F
Aging (Albany NY); 2021 Mar; 13(6):9085-9107. PubMed ID: 33735110
[TBL] [Abstract][Full Text] [Related]
33. Reduced expression of microRNA-497 is associated with greater angiogenesis and poor prognosis in human gliomas.
Feng F; Kuai D; Wang H; Li T; Miao W; Liu Y; Fan Y
Hum Pathol; 2016 Dec; 58():47-53. PubMed ID: 27569294
[TBL] [Abstract][Full Text] [Related]
34. miR-320a functions as a suppressor for gliomas by targeting SND1 and β-catenin, and predicts the prognosis of patients.
Li H; Yu L; Liu J; Bian X; Shi C; Sun C; Zhou X; Wen Y; Hua D; Zhao S; Ren L; An T; Luo W; Wang Q; Yu S
Oncotarget; 2017 Mar; 8(12):19723-19737. PubMed ID: 28160566
[TBL] [Abstract][Full Text] [Related]
35. A-kinase interacting protein 1 is sufficiently expressed and positively associates with WHO grade, meanwhile predicts unfavorable overall survival independently in glioma patients.
Shen S; Yao Y
Medicine (Baltimore); 2021 Jan; 100(4):e20426. PubMed ID: 33530151
[TBL] [Abstract][Full Text] [Related]
36. MiRNA expression profiling in human gliomas: upregulated miR-363 increases cell survival and proliferation.
Conti A; Romeo SG; Cama A; La Torre D; Barresi V; Pezzino G; Tomasello C; Cardali S; Angileri FF; Polito F; Ferlazzo G; Di Giorgio R; Germanò A; Aguennouz M
Tumour Biol; 2016 Oct; 37(10):14035-14048. PubMed ID: 27495233
[TBL] [Abstract][Full Text] [Related]
37. ACTC1 as an invasion and prognosis marker in glioma.
Ohtaki S; Wanibuchi M; Kataoka-Sasaki Y; Sasaki M; Oka S; Noshiro S; Akiyama Y; Mikami T; Mikuni N; Kocsis JD; Honmou O
J Neurosurg; 2017 Feb; 126(2):467-475. PubMed ID: 27081897
[TBL] [Abstract][Full Text] [Related]
38. Correlation of expression levels of ANXA2, PGAM1, and CALR with glioma grade and prognosis.
Gao H; Yu B; Yan Y; Shen J; Zhao S; Zhu J; Qin W; Gao Y
J Neurosurg; 2013 Apr; 118(4):846-53. PubMed ID: 23082878
[TBL] [Abstract][Full Text] [Related]
39. RIZ1: a potential tumor suppressor in glioma.
Zhang C; Zhu Q; He H; Jiang L; Qiang Q; Hu L; Hu G; Jiang Y; Ding X; Lu Y
BMC Cancer; 2015 Dec; 15():990. PubMed ID: 26690953
[TBL] [Abstract][Full Text] [Related]
40. High CHI3L1 expression is associated with glioma patient survival.
Steponaitis G; Skiriutė D; Kazlauskas A; Golubickaitė I; Stakaitis R; Tamašauskas A; Vaitkienė P
Diagn Pathol; 2016 Apr; 11():42. PubMed ID: 27121858
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]